For companies where several teams build separately.
Pharmaceutical design systems for organisations with more than one digital property: a component library markets, agencies and internal teams build from, so the estate stops diverging every time someone launches something.
A design system is worth building when several teams produce interfaces independently. One website does not need one; a corporate site plus six affiliate sites plus a portal plus whatever the last agency delivered does, because otherwise every property drifts.
An audit of what already exists, the token and component library, documentation and usage rules, and the governance that decides who may extend it.
We build the design system to carry your existing brand identity digitally across every property, keeping the identity itself exactly as your brand team defined it.
The variation a pharmaceutical design system has had to absorb in our projects.
The divergence has a cause, and it is usually structural. Pharmaceutical design systems address it at the source.
What to establish before investing in a system.
Almost certainly not. A single site needs a coherent component library inside its own build, which is part of any properly implemented project. A design system is for when several teams build separately, and building one earlier is cost without benefit.
No, it implements them in a digital context. Brand guidelines were usually written for print and leave out focus states, error handling and responsive behaviour entirely. The design system is the digital layer that sits underneath the identity, translating it into working interfaces rather than replacing any part of it.
Governance and usefulness in practice. Teams adopt a system when using it is faster than rebuilding from scratch, which means real code, real documentation and components that cover the real cases teams encounter daily. Systems that exist only as design files, disconnected from code, get ignored reliably over time.
That is exactly what the token layer is for. Local variation happens through theming rather than through forking the codebase, which is the difference between a system that holds together over time and a set of divergent copies that drift apart from a shared origin.
Design system work usually accompanies a redesign or a multi-market rollout. These are the services it sits with.
An estate that has diverged, or a rollout across markets that has to stay coherent. Tell us how many teams build and we will tell you whether a pharmaceutical design system is worth it.